EyeNet Magazine.
There is controversy about the effectiveness of CXL for post-keratorefractive ectasia, but Dr. Hafezi said that in his experience, it is as effective in this setting
as with those other conditions, citing follow-up of 26 eyes from 11 countries up to five years after refractive surgery. He added that a dozen small case studies have reported similar results in a total of about 120 eyes.
